<DOC>
	<DOCNO>NCT01367990</DOCNO>
	<brief_summary>The study evaluate safety topical norepinephrine head neck cancer patient receive treatment intensity modulate radiotherapy ( IMRT ) . The study also provide information whether topical norepinephrine prevent decrease severity radiation-induced alopecia experience patient .</brief_summary>
	<brief_title>Exploratory Study Norepinephrine Prevent Alopecia Head Neck Cancer Patients Treated With Radiotherapy</brief_title>
	<detailed_description />
	<mesh_term>Head Neck Neoplasms</mesh_term>
	<mesh_term>Alopecia</mesh_term>
	<mesh_term>Alopecia Areata</mesh_term>
	<mesh_term>Radiodermatitis</mesh_term>
	<mesh_term>Norepinephrine</mesh_term>
	<criteria>≥ 18 year age document pathological diagnosis H &amp; N ( head neck ) cancer . plan receive H &amp; N region IMRT treatment mean dose dermis scalp risk zone ( isodose plan ) estimate least 20 Gy . palpable nuchal prominence ( external occipital protuberance ) ability understand inform consent document . able comply protocol schedule . negative serum pregnancy test female childbearing potential . consent utilize medically acceptable method contraception throughout study childbearing potential . treat IMRT alone concurrent platinum base chemotherapy receive definitive treatment oropharyngeal squamous cell carcinoma clinical radiographic evidence adenopathy high level V posterior cervical node , postauricular occipital cervical nodal station plan receive H &amp; N region treatment mean dose dermis scalp risk zone ( isodose plan ) estimate exceed 50Gy underlie active untreated cardiac disease ( e.g . arrhythmia ) receive concurrent chemotherapy single agent platinum base generalized skin disorder require treatment within past 6 month . connective tissue disorder unhealed wound scar study area rash , ulceration , poorly heal scar treatment area know allergy norepinephrine know clinically significant abnormal ECG ( electrocardiogram ) within past 6 month . take MAO ( monoamine oxidase ) inhibitor antidepressant triptyline imipramine type take βblockers NCICTCAE Version 4.0 grade 2 high hypertension time study entry .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2012</verification_date>
	<keyword>alopecia</keyword>
	<keyword>hair loss</keyword>
	<keyword>prevention</keyword>
	<keyword>radiotherapy</keyword>
	<keyword>head &amp; neck cancer</keyword>
	<keyword>radiodermatitis</keyword>
	<keyword>radiation dermatitis</keyword>
	<keyword>radiation-induced alopecia</keyword>
</DOC>